nadifloxacin has been researched along with Skin Diseases, Bacterial in 3 studies
nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source
Skin Diseases, Bacterial: Skin diseases caused by bacteria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nadifloxacin was active against all aerobic and anaerobic isolates." | 1.32 | Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections. ( Haustein, UF; Hittel, N; Nenoff, P, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanayama, S | 1 |
| Ikeda, F | 1 |
| Okamoto, K | 1 |
| Nakajima, A | 1 |
| Matsumoto, T | 1 |
| Ishii, R | 1 |
| Amano, A | 1 |
| Matsuzaki, K | 1 |
| Matsumoto, S | 1 |
| Nenoff, P | 1 |
| Haustein, UF | 1 |
| Hittel, N | 1 |
| Komagata, Y | 1 |
| Komiyama, K | 1 |
| Nomura, S | 1 |
3 other studies available for nadifloxacin and Skin Diseases, Bacterial
| Article | Year |
|---|---|
In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Female; | 2016 |
Activity of nadifloxacin (OPC-7251) and seven other antimicrobial agents against aerobic and anaerobic Gram-positive bacteria isolated from bacterial skin infections.
Topics: Administration, Topical; Bacteria, Aerobic; Bacteria, Anaerobic; DNA Damage; Fluoroquinolones; Gram- | 2004 |
[Fundamental studies on antibacterial activity of clindamycin against Propionibacterium acnes].
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clindamycin; Dose-Re | 1998 |